0001562180-23-005105.txt : 20230613
0001562180-23-005105.hdr.sgml : 20230613
20230613162455
ACCESSION NUMBER: 0001562180-23-005105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alpern Paul L
CENTRAL INDEX KEY: 0001888542
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40960
FILM NUMBER: 231011494
MAIL ADDRESS:
STREET 1: C/O ARTERIS, INC.
STREET 2: 595 MILLICH DR., SUITE 200
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arteris, Inc.
CENTRAL INDEX KEY: 0001667011
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 595 MILLICH DR., SUITE 200
CITY: CAMPBELL
STATE: CA
ZIP: 95008
BUSINESS PHONE: (408) 470-7300
MAIL ADDRESS:
STREET 1: 595 MILLICH DR., SUITE 200
CITY: CAMPBELL
STATE: CA
ZIP: 95008
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-09
false
0001667011
Arteris, Inc.
AIP
0001888542
Alpern Paul L
C/O ARTERIS, INC.
595 MILLICH DR., SUITE 200
CAMPBELL
CA
95008
false
true
false
false
VP and General Counsel
true
Common Stock
2023-06-09
4
M
false
40000.00
0.60
A
88953.00
D
Common Stock
2023-06-09
4
S
false
42051.00
7.3344
D
46902.00
D
Stock Options (Right to Buy)
0.60
2023-06-09
4
M
false
40000.00
0.00
D
2030-07-22
Common Stock
40000.00
20000.00
D
Stock Options (Right to Buy)
0.56
2029-10-23
Common Stock
200000.00
200000.00
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
25% of the total shares shall vest on July 23 2021; thereafter, 1/48th of the total shares shall vest monthly for 3 years. beginning on August 23, 2021.
Includes 46,902 restricted stock units.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.55 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares subject to the stock option will vest and become exercisable with respect to 25% of the shares on August 26, 2020 and in 36 substantially equal monthly installments thereafter.
/s/ Paul Alpern
2023-06-13